Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Interleukin 17A Market Insights, Forecast to 2030

Global Interleukin 17A Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-04-15

Pages: 93 Pages

Report ld: 2832886

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Interleukin 17A market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:
This report presents an overview of global market for Interleukin 17A, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Interleukin 17A, also provides the sales of main regions and countries. of the upcoming market potential for Interleukin 17A, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Interleukin 17A sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Interleukin 17A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Interleukin 17A sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Report Metric
Details
Report Title
Global Interleukin 17A Market Insights, Forecast to 2030
Global Interleukin 17A Companies Covered
AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG, Orega Biotech SAS
Global Interleukin 17A Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Interleukin 17A Market, Segment by Type
ABY-035

CNTO-6785

DLX-2882

Others
Global Interleukin 17A Market, Segment by Application
Chronic Pain

Liver Cancer

Kidney Cancer

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Interleukin 17A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interleukin 17A sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Table of Contents

 1 Study Coverage
    1.1 Interleukin 17A Product Introduction
    1.2 Market by Type
        1.2.1 Global Interleukin 17A Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 ABY-035
        1.2.3 CNTO-6785
        1.2.4 DLX-2882
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Interleukin 17A Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Chronic Pain
        1.3.3 Liver Cancer
        1.3.4 Kidney Cancer
        1.3.5 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Interleukin 17A Sales Estimates and Forecasts 2019-2030
    2.2 Global Interleukin 17A Revenue by Region
        2.2.1 Global Interleukin 17A Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Interleukin 17A Revenue by Region (2019-2024)
        2.2.3 Global Interleukin 17A Revenue by Region (2025-2030)
        2.2.4 Global Interleukin 17A Revenue Market Share by Region (2019-2030)
    2.3 Global Interleukin 17A Sales Estimates and Forecasts 2019-2030
    2.4 Global Interleukin 17A Sales by Region
        2.4.1 Global Interleukin 17A Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Interleukin 17A Sales by Region (2019-2024)
        2.4.3 Global Interleukin 17A Sales by Region (2025-2030)
        2.4.4 Global Interleukin 17A Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufactures
    3.1 Global Interleukin 17A Sales by Manufacturers
        3.1.1 Global Interleukin 17A Sales by Manufacturers (2019-2024)
        3.1.2 Global Interleukin 17A Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Interleukin 17A in 2023
    3.2 Global Interleukin 17A Revenue by Manufacturers
        3.2.1 Global Interleukin 17A Revenue by Manufacturers (2019-2024)
        3.2.2 Global Interleukin 17A Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Interleukin 17A Revenue in 2023
    3.3 Global Key Players of Interleukin 17A, Industry Ranking, 2022 VS 2023 VS 2024
    3.4 Global Interleukin 17A Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Interleukin 17A, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Interleukin 17A, Product Offered and Application
    3.8 Global Key Manufacturers of Interleukin 17A, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Interleukin 17A Sales by Type
        4.1.1 Global Interleukin 17A Historical Sales by Type (2019-2024)
        4.1.2 Global Interleukin 17A Forecasted Sales by Type (2025-2030)
        4.1.3 Global Interleukin 17A Sales Market Share by Type (2019-2030)
    4.2 Global Interleukin 17A Revenue by Type
        4.2.1 Global Interleukin 17A Historical Revenue by Type (2019-2024)
        4.2.2 Global Interleukin 17A Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Interleukin 17A Revenue Market Share by Type (2019-2030)
    4.3 Global Interleukin 17A Price by Type
        4.3.1 Global Interleukin 17A Price by Type (2019-2024)
        4.3.2 Global Interleukin 17A Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Interleukin 17A Sales by Application
        5.1.1 Global Interleukin 17A Historical Sales by Application (2019-2024)
        5.1.2 Global Interleukin 17A Forecasted Sales by Application (2025-2030)
        5.1.3 Global Interleukin 17A Sales Market Share by Application (2019-2030)
    5.2 Global Interleukin 17A Revenue by Application
        5.2.1 Global Interleukin 17A Historical Revenue by Application (2019-2024)
        5.2.2 Global Interleukin 17A Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Interleukin 17A Revenue Market Share by Application (2019-2030)
    5.3 Global Interleukin 17A Price by Application
        5.3.1 Global Interleukin 17A Price by Application (2019-2024)
        5.3.2 Global Interleukin 17A Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Interleukin 17A Market Size by Type
        6.1.1 US & Canada Interleukin 17A Sales by Type (2019-2030)
        6.1.2 US & Canada Interleukin 17A Revenue by Type (2019-2030)
    6.2 US & Canada Interleukin 17A Market Size by Application
        6.2.1 US & Canada Interleukin 17A Sales by Application (2019-2030)
        6.2.2 US & Canada Interleukin 17A Revenue by Application (2019-2030)
    6.3 US & Canada Interleukin 17A Market Size by Country
        6.3.1 US & Canada Interleukin 17A Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Interleukin 17A Sales by Country (2019-2030)
        6.3.3 US & Canada Interleukin 17A Revenue by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Interleukin 17A Market Size by Type
        7.1.1 Europe Interleukin 17A Sales by Type (2019-2030)
        7.1.2 Europe Interleukin 17A Revenue by Type (2019-2030)
    7.2 Europe Interleukin 17A Market Size by Application
        7.2.1 Europe Interleukin 17A Sales by Application (2019-2030)
        7.2.2 Europe Interleukin 17A Revenue by Application (2019-2030)
    7.3 Europe Interleukin 17A Market Size by Country
        7.3.1 Europe Interleukin 17A Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Interleukin 17A Sales by Country (2019-2030)
        7.3.3 Europe Interleukin 17A Revenue by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Interleukin 17A Market Size
        8.1.1 China Interleukin 17A Sales  (2019-2030)
        8.1.2 China Interleukin 17A Revenue  (2019-2030)
    8.2 China Interleukin 17A Market Size by Application
        8.2.1 China Interleukin 17A Sales by Application (2019-2030)
        8.2.2 China Interleukin 17A Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Interleukin 17A Market Size by Type
        9.1.1 Asia Interleukin 17A Sales by Type (2019-2030)
        9.1.2 Asia Interleukin 17A Revenue by Type (2019-2030)
    9.2 Asia Interleukin 17A Market Size by Application
        9.2.1 Asia Interleukin 17A Sales by Application (2019-2030)
        9.2.2 Asia Interleukin 17A Revenue by Application (2019-2030)
    9.3 Asia Interleukin 17A Sales by Region
        9.3.1 Asia Interleukin 17A Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Interleukin 17A Revenue by Region (2019-2030)
        9.3.3 Asia Interleukin 17A Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Interleukin 17A Market Size by Type
        10.1.1 Middle East, Africa and Latin America Interleukin 17A Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Interleukin 17A Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Interleukin 17A Market Size by Application
        10.2.1 Middle East, Africa and Latin America Interleukin 17A Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Interleukin 17A Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Interleukin 17A Sales by Country
        10.3.1 Middle East, Africa and Latin America Interleukin 17A Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Interleukin 17A Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Interleukin 17A Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Company Profiles
    11.1 AbbVie Inc
        11.1.1 AbbVie Inc Company Information
        11.1.2 AbbVie Inc Overview
        11.1.3 AbbVie Inc Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 AbbVie Inc Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AbbVie Inc Recent Developments
    11.2 Abeome Corporation
        11.2.1 Abeome Corporation Company Information
        11.2.2 Abeome Corporation Overview
        11.2.3 Abeome Corporation Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 Abeome Corporation Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Abeome Corporation Recent Developments
    11.3 Affibody AB
        11.3.1 Affibody AB Company Information
        11.3.2 Affibody AB Overview
        11.3.3 Affibody AB Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Affibody AB Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Affibody AB Recent Developments
    11.4 Cell Medica Limited
        11.4.1 Cell Medica Limited Company Information
        11.4.2 Cell Medica Limited Overview
        11.4.3 Cell Medica Limited Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 Cell Medica Limited Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Cell Medica Limited Recent Developments
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Company Information
        11.5.2 Eli Lilly and Company Overview
        11.5.3 Eli Lilly and Company Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 Eli Lilly and Company Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Eli Lilly and Company Recent Developments
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Information
        11.6.2 Johnson & Johnson Overview
        11.6.3 Johnson & Johnson Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 Johnson & Johnson Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Johnson & Johnson Recent Developments
    11.7 Merck KGaA
        11.7.1 Merck KGaA Company Information
        11.7.2 Merck KGaA Overview
        11.7.3 Merck KGaA Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.7.4 Merck KGaA Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Merck KGaA Recent Developments
    11.8 Novartis AG
        11.8.1 Novartis AG Company Information
        11.8.2 Novartis AG Overview
        11.8.3 Novartis AG Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.8.4 Novartis AG Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Novartis AG Recent Developments
    11.9 Orega Biotech SAS
        11.9.1 Orega Biotech SAS Company Information
        11.9.2 Orega Biotech SAS Overview
        11.9.3 Orega Biotech SAS Interleukin 17A Sales, Price, Revenue and Gross Margin (2019-2024)
        11.9.4 Orega Biotech SAS Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Orega Biotech SAS Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Interleukin 17A Industry Chain Analysis
    12.2 Interleukin 17A Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Interleukin 17A Production Mode & Process
    12.4 Interleukin 17A Sales and Marketing
        12.4.1 Interleukin 17A Sales Channels
        12.4.2 Interleukin 17A Distributors
    12.5 Interleukin 17A Customers

 13 Market Dynamics
    13.1 Interleukin 17A Industry Trends
    13.2 Interleukin 17A Market Drivers
    13.3 Interleukin 17A Market Challenges
    13.4 Interleukin 17A Market Restraints

 14 Key Findings in The Global Interleukin 17A Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Interleukin 17A Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of ABY-035
    Table 3. Major Manufacturers of CNTO-6785
    Table 4. Major Manufacturers of DLX-2882
    Table 5. Major Manufacturers of Others
    Table 6. Global Interleukin 17A Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Interleukin 17A Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Interleukin 17A Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Interleukin 17A Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Interleukin 17A Revenue Market Share by Region (2019-2024)
    Table 11. Global Interleukin 17A Revenue Market Share by Region (2025-2030)
    Table 12. Global Interleukin 17A Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Interleukin 17A Sales by Region (2019-2024) & (K Pcs)
    Table 14. Global Interleukin 17A Sales by Region (2025-2030) & (K Pcs)
    Table 15. Global Interleukin 17A Sales Market Share by Region (2019-2024)
    Table 16. Global Interleukin 17A Sales Market Share by Region (2025-2030)
    Table 17. Global Interleukin 17A Sales by Manufacturers (2019-2024) & (K Pcs)
    Table 18. Global Interleukin 17A Sales Share by Manufacturers (2019-2024)
    Table 19. Global Interleukin 17A Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Interleukin 17A Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Interleukin 17A, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Interleukin 17A Price by Manufacturers 2019-2024 (USD/Pcs)
    Table 23. Global Interleukin 17A Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Interleukin 17A by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interleukin 17A as of 2023)
    Table 25. Global Key Manufacturers of Interleukin 17A, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Interleukin 17A, Product Offered and Application
    Table 27. Global Key Manufacturers of Interleukin 17A, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Interleukin 17A Sales by Type (2019-2024) & (K Pcs)
    Table 30. Global Interleukin 17A Sales by Type (2025-2030) & (K Pcs)
    Table 31. Global Interleukin 17A Sales Share by Type (2019-2024)
    Table 32. Global Interleukin 17A Sales Share by Type (2025-2030)
    Table 33. Global Interleukin 17A Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Interleukin 17A Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Interleukin 17A Revenue Share by Type (2019-2024)
    Table 36. Global Interleukin 17A Revenue Share by Type (2025-2030)
    Table 37. Interleukin 17A Price by Type (2019-2024) & (USD/Pcs)
    Table 38. Global Interleukin 17A Price Forecast by Type (2025-2030) & (USD/Pcs)
    Table 39. Global Interleukin 17A Sales by Application (2019-2024) & (K Pcs)
    Table 40. Global Interleukin 17A Sales by Application (2025-2030) & (K Pcs)
    Table 41. Global Interleukin 17A Sales Share by Application (2019-2024)
    Table 42. Global Interleukin 17A Sales Share by Application (2025-2030)
    Table 43. Global Interleukin 17A Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Interleukin 17A Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Interleukin 17A Revenue Share by Application (2019-2024)
    Table 46. Global Interleukin 17A Revenue Share by Application (2025-2030)
    Table 47. Interleukin 17A Price by Application (2019-2024) & (USD/Pcs)
    Table 48. Global Interleukin 17A Price Forecast by Application (2025-2030) & (USD/Pcs)
    Table 49. US & Canada Interleukin 17A Sales by Type (2019-2024) & (K Pcs)
    Table 50. US & Canada Interleukin 17A Sales by Type (2025-2030) & (K Pcs)
    Table 51. US & Canada Interleukin 17A Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Interleukin 17A Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Interleukin 17A Sales by Application (2019-2024) & (K Pcs)
    Table 54. US & Canada Interleukin 17A Sales by Application (2025-2030) & (K Pcs)
    Table 55. US & Canada Interleukin 17A Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Interleukin 17A Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Interleukin 17A Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Interleukin 17A Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Interleukin 17A Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Interleukin 17A Sales by Country (2019-2024) & (K Pcs)
    Table 61. US & Canada Interleukin 17A Sales by Country (2025-2030) & (K Pcs)
    Table 62. Europe Interleukin 17A Sales by Type (2019-2024) & (K Pcs)
    Table 63. Europe Interleukin 17A Sales by Type (2025-2030) & (K Pcs)
    Table 64. Europe Interleukin 17A Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Interleukin 17A Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Interleukin 17A Sales by Application (2019-2024) & (K Pcs)
    Table 67. Europe Interleukin 17A Sales by Application (2025-2030) & (K Pcs)
    Table 68. Europe Interleukin 17A Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Interleukin 17A Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Interleukin 17A Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Interleukin 17A Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Interleukin 17A Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Interleukin 17A Sales by Country (2019-2024) & (K Pcs)
    Table 74. Europe Interleukin 17A Sales by Country (2025-2030) & (K Pcs)
    Table 75. China Interleukin 17A Sales by Type (2019-2024) & (K Pcs)
    Table 76. China Interleukin 17A Sales by Type (2025-2030) & (K Pcs)
    Table 77. China Interleukin 17A Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Interleukin 17A Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Interleukin 17A Sales by Application (2019-2024) & (K Pcs)
    Table 80. China Interleukin 17A Sales by Application (2025-2030) & (K Pcs)
    Table 81. China Interleukin 17A Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Interleukin 17A Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Interleukin 17A Sales by Type (2019-2024) & (K Pcs)
    Table 84. Asia Interleukin 17A Sales by Type (2025-2030) & (K Pcs)
    Table 85. Asia Interleukin 17A Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Interleukin 17A Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Interleukin 17A Sales by Application (2019-2024) & (K Pcs)
    Table 88. Asia Interleukin 17A Sales by Application (2025-2030) & (K Pcs)
    Table 89. Asia Interleukin 17A Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Interleukin 17A Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Interleukin 17A Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Interleukin 17A Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Interleukin 17A Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Interleukin 17A Sales by Region (2019-2024) & (K Pcs)
    Table 95. Asia Interleukin 17A Sales by Region (2025-2030) & (K Pcs)
    Table 96. Middle East, Africa and Latin America Interleukin 17A Sales by Type (2019-2024) & (K Pcs)
    Table 97. Middle East, Africa and Latin America Interleukin 17A Sales by Type (2025-2030) & (K Pcs)
    Table 98. Middle East, Africa and Latin America Interleukin 17A Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Interleukin 17A Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Interleukin 17A Sales by Application (2019-2024) & (K Pcs)
    Table 101. Middle East, Africa and Latin America Interleukin 17A Sales by Application (2025-2030) & (K Pcs)
    Table 102. Middle East, Africa and Latin America Interleukin 17A Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Interleukin 17A Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Interleukin 17A Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Interleukin 17A Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Interleukin 17A Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Interleukin 17A Sales by Country (2019-2024) & (K Pcs)
    Table 108. Middle East, Africa and Latin America Interleukin 17A Sales by Country (2025-2030) & (K Pcs)
    Table 109. AbbVie Inc Company Information
    Table 110. AbbVie Inc Description and Major Businesses
    Table 111. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 112. AbbVie Inc Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. AbbVie Inc Recent Developments
    Table 114. Abeome Corporation Company Information
    Table 115. Abeome Corporation Description and Major Businesses
    Table 116. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 117. Abeome Corporation Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Abeome Corporation Recent Developments
    Table 119. Affibody AB Company Information
    Table 120. Affibody AB Description and Major Businesses
    Table 121. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 122. Affibody AB Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Affibody AB Recent Developments
    Table 124. Cell Medica Limited Company Information
    Table 125. Cell Medica Limited Description and Major Businesses
    Table 126. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 127. Cell Medica Limited Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Cell Medica Limited Recent Developments
    Table 129. Eli Lilly and Company Company Information
    Table 130. Eli Lilly and Company Description and Major Businesses
    Table 131. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 132. Eli Lilly and Company Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Eli Lilly and Company Recent Developments
    Table 134. Johnson & Johnson Company Information
    Table 135. Johnson & Johnson Description and Major Businesses
    Table 136. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 137. Johnson & Johnson Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Johnson & Johnson Recent Developments
    Table 139. Merck KGaA Company Information
    Table 140. Merck KGaA Description and Major Businesses
    Table 141. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 142. Merck KGaA Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Merck KGaA Recent Developments
    Table 144. Novartis AG Company Information
    Table 145. Novartis AG Description and Major Businesses
    Table 146. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 147. Novartis AG Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Novartis AG Recent Developments
    Table 149. Orega Biotech SAS Company Information
    Table 150. Orega Biotech SAS Description and Major Businesses
    Table 151. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 152. Orega Biotech SAS Interleukin 17A Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Orega Biotech SAS Recent Developments
    Table 154. Key Raw Materials Lists
    Table 155. Raw Materials Key Suppliers Lists
    Table 156. Interleukin 17A Distributors List
    Table 157. Interleukin 17A Customers List
    Table 158. Interleukin 17A Market Trends
    Table 159. Interleukin 17A Market Drivers
    Table 160. Interleukin 17A Market Challenges
    Table 161. Interleukin 17A Market Restraints
    Table 162. Research Programs/Design for This Report
    Table 163. Key Data Information from Secondary Sources
    Table 164. Key Data Information from Primary Sources
List of Figures
    Figure 1. Interleukin 17A Product Picture
    Figure 2. Global Interleukin 17A Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Interleukin 17A Market Share by Type in 2023 & 2030
    Figure 4. ABY-035 Product Picture
    Figure 5. CNTO-6785 Product Picture
    Figure 6. DLX-2882 Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Interleukin 17A Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Interleukin 17A Market Share by Application in 2023 & 2030
    Figure 10. Chronic Pain
    Figure 11. Liver Cancer
    Figure 12. Kidney Cancer
    Figure 13. Others
    Figure 14. Interleukin 17A Report Years Considered
    Figure 15. Global Interleukin 17A Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Interleukin 17A Revenue 2019-2030 (US$ Million)
    Figure 17. Global Interleukin 17A Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Interleukin 17A Revenue Market Share by Region (2019-2030)
    Figure 19. Global Interleukin 17A Sales 2019-2030 ((K Pcs)
    Figure 20. Global Interleukin 17A Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada Interleukin 17A Sales YoY (2019-2030) & (K Pcs)
    Figure 22. US & Canada Interleukin 17A Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Interleukin 17A Sales YoY (2019-2030) & (K Pcs)
    Figure 24. Europe Interleukin 17A Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China Interleukin 17A Sales YoY (2019-2030) & (K Pcs)
    Figure 26. China Interleukin 17A Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) Interleukin 17A Sales YoY (2019-2030) & (K Pcs)
    Figure 28. Asia (excluding China) Interleukin 17A Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Interleukin 17A Sales YoY (2019-2030) & (K Pcs)
    Figure 30. Middle East, Africa and Latin America Interleukin 17A Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The Interleukin 17A Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of Interleukin 17A in the World: Market Share by Interleukin 17A Revenue in 2023
    Figure 33. Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global Interleukin 17A Sales Market Share by Type (2019-2030)
    Figure 35. Global Interleukin 17A Revenue Market Share by Type (2019-2030)
    Figure 36. Global Interleukin 17A Sales Market Share by Application (2019-2030)
    Figure 37. Global Interleukin 17A Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Interleukin 17A Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada Interleukin 17A Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada Interleukin 17A Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada Interleukin 17A Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada Interleukin 17A Revenue Share by Country (2019-2030)
    Figure 43. US & Canada Interleukin 17A Sales Share by Country (2019-2030)
    Figure 44. U.S. Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Interleukin 17A Sales Market Share by Type (2019-2030)
    Figure 47. Europe Interleukin 17A Revenue Market Share by Type (2019-2030)
    Figure 48. Europe Interleukin 17A Sales Market Share by Application (2019-2030)
    Figure 49. Europe Interleukin 17A Revenue Market Share by Application (2019-2030)
    Figure 50. Europe Interleukin 17A Revenue Share by Country (2019-2030)
    Figure 51. Europe Interleukin 17A Sales Share by Country (2019-2030)
    Figure 52. Germany Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 53. France Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 57. China Interleukin 17A Sales Market Share by Type (2019-2030)
    Figure 58. China Interleukin 17A Revenue Market Share by Type (2019-2030)
    Figure 59. China Interleukin 17A Sales Market Share by Application (2019-2030)
    Figure 60. China Interleukin 17A Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Interleukin 17A Sales Market Share by Type (2019-2030)
    Figure 62. Asia Interleukin 17A Revenue Market Share by Type (2019-2030)
    Figure 63. Asia Interleukin 17A Sales Market Share by Application (2019-2030)
    Figure 64. Asia Interleukin 17A Revenue Market Share by Application (2019-2030)
    Figure 65. Asia Interleukin 17A Revenue Share by Region (2019-2030)
    Figure 66. Asia Interleukin 17A Sales Share by Region (2019-2030)
    Figure 67. Japan Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 71. India Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Interleukin 17A Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Interleukin 17A Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Interleukin 17A Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Interleukin 17A Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Interleukin 17A Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America Interleukin 17A Sales Share by Country (2019-2030)
    Figure 78. Brazil Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries Interleukin 17A Revenue (2019-2030) & (US$ Million)
    Figure 83. Interleukin 17A Value Chain
    Figure 84. Interleukin 17A Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed

Description

The global Interleukin 17A market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Interleukin 17A is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Market Segmentation